MARK4ΔG316E317D increases tau levels and tau toxicity in a Ser-262/356–independent manner.
A, MARK4ΔG316E317D positively regulated tau levels in a Ser-262/356–independent manner. Western blots of fly heads expressing S2A tau alone or coexpressing S2A tau with either MARK4wt (S2A tau+MARK4wt) or MARK4ΔG316E317D (S2A tau+MARK4ΔG316E317D). Means ± S.D. (error bars), n = 4. n.s. (not significant), p > 0.05; ***p < 0.005 (one-way ANOVA and Tukey's post-hoc test). B, coexpression of S2A tau with MARK4ΔG316E317D, but not with MARK4wt, enhanced neurodegeneration. Shown are lamina of flies harboring expressing S2A tau (S2A tau), coexpressing S2A tau and MARK4wt (S2A tau+MARK4wt), or coexpressing S2A tau and MARK4ΔG316E317D (S2A tau+MARK4ΔG316E317D). Means ± S.E. (error bars); n = 5. n.s. (not significant), p > 0.05; ***p < 0.005 (one-way ANOVA and Tukey's post-hoc test).